Bifidobacteria for treating diabetes and related conditions
AssigneeDupont Nutrition Biosciences Aps
InventorsRémy Burcelin, Didier Carcano, Sampo Lahtinen
Life of this patent
Estimating the term…
Abstract
This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.
Claims18
A method of treating myocardial infarction in a mammal, the method comprising administering to a mammal in need of such treatment a bacterium of the genus Bifidobacterium or a mixture thereof.
Dependencies are inferred from the claim text.